ARCHIVES

Proposed FDA Charges For NDA Drugs, Biologics Submissions Would Total $76 Million In FY 1990

This article is from The Cancer Letter archive.

Vol. 15 No. 04 | January 27, 1989

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: NCI Offers Grant Supplements

March 5, 1999

Q & A: NCI’s Doroshow Says Phase I Program Will Stress Correlative Studies for Small Biotech Firms

April 6, 2012

Letter to the Editor

March 21, 2003

Relative Survival Now May be Over 50%, DeVita Says

December 3, 1982

NCI-Funded Trials Show Aspirin Reduces Recurrence of Polyps

March 28, 2003

Satraplatin With Prednisone Reduces Risk Of Disease Progression By 33% In Study

March 30, 2007